ASB14

ankyrin repeat and SOCS box containing 14, the group of Ankyrin repeat domain containing

Basic information

Region (hg38): 3:57268342-57292685

Links

ENSG00000239388NCBI:142686HGNC:19766Uniprot:A6NK59AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ASB14 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ASB14 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
43
clinvar
3
clinvar
46
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
8
clinvar
4
clinvar
3
clinvar
15
Total 0 0 51 7 3

Variants in ASB14

This is a list of pathogenic ClinVar variants found in the ASB14 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
3-57268402-G-A Uncertain significance (Apr 03, 2023)2717386
3-57268402-G-T Uncertain significance (Aug 01, 2023)2653911
3-57268420-A-G Uncertain significance (Dec 02, 2022)2961791
3-57268429-TAGAG-T not specified Conflicting classifications of pathogenicity (Feb 27, 2023)1315697
3-57268430-A-G Maturity-onset diabetes of the young type 14 Likely benign (Apr 17, 2022)1678586
3-57268437-G-C not specified Uncertain significance (Aug 12, 2022)2306817
3-57268465-A-G Conflicting classifications of pathogenicity (Jan 02, 2024)1318138
3-57268491-T-C not specified Uncertain significance (Jul 05, 2024)3339120
3-57268492-A-G APPL1-related disorder Likely benign (May 25, 2022)3034768
3-57268494-A-G Likely benign (Jul 19, 2022)1551890
3-57269450-A-AGAATT Benign (Aug 30, 2018)1235569
3-57269520-C-CT Benign (Oct 17, 2023)2428543
3-57269575-C-G not specified Conflicting classifications of pathogenicity (May 20, 2024)1336471
3-57269603-G-A Likely benign (May 31, 2022)2089130
3-57269629-G-A not specified Uncertain significance (Jun 24, 2022)1466213
3-57269656-A-G Benign (Jan 29, 2024)1168989
3-57269668-A-G Uncertain significance (Jul 21, 2022)1923374
3-57269684-A-G Uncertain significance (Dec 30, 2021)1422648
3-57276572-C-T not specified Uncertain significance (Mar 01, 2023)2462089
3-57276588-C-T not specified Uncertain significance (Mar 02, 2023)2473060
3-57276621-G-A not specified Uncertain significance (Nov 15, 2021)2382701
3-57276621-G-T not specified Uncertain significance (Jul 14, 2021)2388792
3-57276659-C-T not specified Uncertain significance (Jan 10, 2022)2399235
3-57276660-G-A not specified Uncertain significance (Apr 13, 2023)2514614
3-57276679-G-C not specified Uncertain significance (Apr 18, 2023)2525371

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ASB14protein_codingprotein_codingENST00000487349 924336
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
1.12e-220.00008001256810651257460.000258
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.4222963170.9330.00001633838
Missense in Polyphen113122.60.921691532
Synonymous0.5541111190.9350.000006231157
Loss of Function-1.153023.91.250.00000116317

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.001270.00127
Ashkenazi Jewish0.0001990.000198
East Asian0.0007160.000707
Finnish0.00004660.0000462
European (Non-Finnish)0.0001420.000141
Middle Eastern0.0007160.000707
South Asian0.0001630.000163
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: May be a substrate-recognition component of a SCF-like ECS (Elongin-Cullin-SOCS-box protein) E3 ubiquitin-protein ligase complex which mediates the ubiquitination and subsequent proteasomal degradation of target proteins. {ECO:0000250}.;
Pathway
Post-translational protein modification;Metabolism of proteins;Immune System;Adaptive Immune System;Antigen processing: Ubiquitination & Proteasome degradation;Class I MHC mediated antigen processing & presentation;Neddylation (Consensus)

Intolerance Scores

loftool
0.917
rvis_EVS
-0.73
rvis_percentile_EVS
14.02

Haploinsufficiency Scores

pHI
0.222
hipred
N
hipred_score
0.167
ghis
0.531

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
N
gene_indispensability_score
0.0565

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Asb14
Phenotype

Gene ontology

Biological process
protein ubiquitination;intracellular signal transduction;post-translational protein modification
Cellular component
cytosol
Molecular function